Skip to main content
SpringerLink
Log in

Chemotherapie des nichtkleinzelligen Lungenkarzinoms

  • Chapter
Thoraxtumoren

Zusammenfassung

Nach traditioneller Auffassung ist mit der Chemotherapie bei nichtkleinzelligen Bronchialkarzinomen nur eine zeitlich außerordentlich befristete und rein palliative Wirkung erreichbar (Bakowski u. Crouch 1983; Joss u. Brunner 1985; Klastersky u. Sculier 1985; Folman u. Rosman 1988; Klastersky 1994; Eberhard et al. 1995). Dabei bezieht man sich in der Regel auf die Ergebnisse der zytostatischen Therapie bei lokal weit fortgeschrittener oder fernmetastasierter Tumorerkrankung.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aaronson NK, Bullinger M, Ahmedzai S (1988) A modular approach to quality-of-life assessment in cancer clinical trials. Ree Results Cancer Res 111: 231–249

    CAS  Google Scholar 

  2. Bakowski MT, Crouch JC (1983) Chemotherapy for non-small cell lung cancer. A reappraisal and a look to the future. Cancer Treat Rep 10: 159–172

    Article  CAS  Google Scholar 

  3. Bischoff HG, Schraube P, Manegold C, Drings P, Wannemacher M (1996) Radiochemotherapy of unresectable non-small cell lung cancer (NSCLC) with Ifosfamide — a phase 1/2 trial. Eur Respir J 9 (Suppl 23): 306 s (1926)

    Google Scholar 

  4. Bishop JF (1995) Scheduling of chemotherapy and radiotherapy in locally advanced non-small cell lung cander. Lung Cancer 12 (Suppl 2): 53–61

    Article  Google Scholar 

  5. Bitran JD, Golomb HM, Hoffmann PC et al. (1986) Pro to chemotherapy in non-small cell lung carcinoma. An attempt to increase surgical resectability and survival: A preliminary report. Cancer 57: 44–53

    Article  PubMed  CAS  Google Scholar 

  6. Bleehen NM (1991) Combined radiotherapy with chemotherapy for inoperable non-small cell lung cancer. Lung Cancer 7: 85–89

    Article  Google Scholar 

  7. Bonomi P, Trybulla M, Sander S et al. (1986) Comparison of neoadjuvant chemotherapy (Neo-CT) alone to simultaneous chemotherapy (SCT-RT) in locally advanced squamous cell bronchogenic carcinoma (sq CBS). Neo-adjuvant chemotherapy. Coll. IN-SERM/John Libbey Eurotext 137: 505–517

    Google Scholar 

  8. Bonomi PD, Finkelstein DM, Ruckdeschel JC et al. (1989) Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small cell lung cancer: A study of the Eastern Cooperative Oncology Group. J Clin Oncol 7 /11: 1602–1613

    PubMed  CAS  Google Scholar 

  9. Brodin OE, Nou E (1991) Patients with nonresectable squamous cell carcinoma of the lung. A prospective randomized study. Lung Cancer 7 (Suppl): 615

    Google Scholar 

  10. Burkes RL, Sheperd FA, Ginsberg RJ et al. (1994) Induction chemotherapy with MVP in patients with stage Ilia (Tl-3, N2, MO) unresectable non-small cell lung cancer (NSCLC): The Toronto experience. Proc Am Soc Clin Oncol 13: 327 (Abstract)

    Google Scholar 

  11. Cartei G, Cartei F, Cantone A et al. (1993) Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small cell lung cancer. J Natl Cancer Inst 85: 794–800

    Article  PubMed  CAS  Google Scholar 

  12. Cellerino R, Tummarello D, Guido F et al. (1991) A randomized trial of alterning chemotherapy versus best supportive care in advanced non-small cell lung cancer. J Clin Oncol 9: 1454–1461

    Google Scholar 

  13. Chapman R, Lewis J, Kvale P et al. (1990) A neoadjuvant trial in stage II and stage Ilia non-small cell lung cancer with cisplatinum and vinblastine chemotherapy. Proc Am Soc Clin Oncol 9: 246–954

    Google Scholar 

  14. Clamon G, Mauer H, Goutsou M et al. (1990) Toxicity and induction chemotherapy response rate for limited stage III non-small cell lung cancer. Preliminary results or a randomized phase II trial. Proc Am Soc Clin Oncol 9: 239 (Abstr)

    Google Scholar 

  15. Clavier J, Zabbè CL, Raut Y et al. (1986) Chimiothérapie préopératoir dans les cancers bronchiques epidermoides. Résultats d’une étude pilote portant sur 60 patients. Neoadjuvant chemotherapy, Coll. INSERM-/John Libbey Eurotext 137/473–478

    Google Scholar 

  16. Cojean I, Le Chevalier T (1995) Chemotherapy of stage III b and IV non-small cell lung cancer. Symposium article. Ann Oncol 6 (Suppl 3): 41–44

    Google Scholar 

  17. Cormier YD, Bergeron J, LA Forge et al. (1982) Benefits of polychemotherapy in advanced non- small cell oronchogenic carcinoma. Cancer 50: 845–849

    Article  PubMed  CAS  Google Scholar 

  18. Cox JD (1991) The respective roles of radiation therapy and chemotherapy in non-small cell carcinoma of the lung with mediastinal but not distant metastasis (N2M0). Lung Cancer 7: 65–69

    Article  Google Scholar 

  19. Crino L, Clerici M, Figoli F et al. (1995) Chemotherapy of advanced non-small cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (GOIRC). Ann Oncol 6: 347–353

    PubMed  CAS  Google Scholar 

  20. Cullen MH (1993) The MIC regimen in non-small cell lung cancer. Lung Cancer 9 (Suppl 2): 81–89

    Article  Google Scholar 

  21. Cullen MH, Joshi R, Cheriyawardana AD, Woodroffe CM (1988) Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer: Treatment good enough to compare. Br J Cancer 58: 359–361

    Article  PubMed  CAS  Google Scholar 

  22. Dillman RO, Seagren SL, Propert KJ et al. (1990) A randomized trial of induction chemotherapy plus high-dose radiation versus radiation in stage III non-small cell lung cancer. N Engl J Med 323: 940–945

    Article  PubMed  CAS  Google Scholar 

  23. Donnadieu N, Paesmans M, Sculier JP (1991) Chemotherapy of non-small cell lung cancer according to disease extent: A metaanalysis of the literature. Lung Cancer 7: 243–252

    Article  Google Scholar 

  24. Drings P, Becker H, Bülzebruck H et al. (1988) Die Chemotherapie des nichtkleinzelligen Bronchialkarzinoms mit Ifosfamid in Kombination mit Cisplatin, Etoposid oder Vindesin. Onkologie 11: 47–56

    Article  PubMed  Google Scholar 

  25. Drings P, Manegold C (1994) Stand der Chemotherapie beim nichtkleinzelligen Bronchialkarzinom. Strahlenther Onkol 170: 495–506

    PubMed  CAS  Google Scholar 

  26. Drings P, Wannenmacher M (1995) Nicht-kleinzellige Bronchialkarzinome. In: Seeber S, Schütte J (Hrsg) Therapiekonzepte Onkologie, 2. Aufl. Springer, Berlin Heidelberg New York, S 446–473

    Google Scholar 

  27. Durrant KR, Berry RJ, Ellis F et al. (1971) Comparison of treatment policies in inoperable bronchial carcinoma. Lancet 1: 715–719

    Article  PubMed  CAS  Google Scholar 

  28. Eberhardt W, Wilke H, Achterrath W, Seeber S (1995) Chemotherapie des nichtkleinzelligen Bronchialkarzinoms. Onkologe 1: 475–481

    Google Scholar 

  29. Fischer JR, Maneeold C, Bülzebruck H, Vogt-Moykopf I, Drings P (1994) Induction chemotherapy witn and without recombinant human granulocyte colony-stimulating fac tor support in localley advanced stage III A/B non-small cell lung cancer. Semin Oncol 21 (Suppl 4): 20–27

    PubMed  CAS  Google Scholar 

  30. Folman RS, Rosman M (1988) The role of chemotherapy in non-small cell lung cancer: the community perspective. Semin Oncol (Suppl 4 ) 15: 16–21

    Google Scholar 

  31. Ganz PA, Figlin RA, Hasekell CM, La Soto N, Siau J (1989) Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Cancer 63: 1271–1278

    Article  PubMed  CAS  Google Scholar 

  32. Gatzemeier U (1995) Chemotherapie oder „best supportive care“beim fortgeschrittenen nichtkleinzelligen Bronchialkarzinom. Onkologe 1: 494–502

    Google Scholar 

  33. Hainsworth J, Johnson D, Hände K (1989) Chemotherapy of advanced non-small cell lung cancer. A randomized trial of three cisplatin-based chemotherapy regimens. Am J Clin Oncol 12: 345–349

    Article  PubMed  CAS  Google Scholar 

  34. Haraf DJ, Devine S, Ihde DC, Vokes EE (1992) The evolving role of systemic therapy in carcinoma of the lung. Semin Oncol (Suppl 11 ) 19: 72–87

    Google Scholar 

  35. Hazuka MB, Bunn PA (1992) Controversies in the nonsurgical treatment of stage III non- small cell lung cancer. Am Rev Respirât Dis 145: 967–977

    CAS  Google Scholar 

  36. Henriques I, Munoz-Galindo L, Rebello J, Vieitez JM, Gonzales-Manzano R, Vargas EA, Santos M, Llorens R, Herreos J (1990) Neoadjuvant chemotherapy (NAC) with cisplatin (CDDP), mitomycin C (MMC) and vindesine (VDS) in locally aavanced non small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1: 227, A 876

    Google Scholar 

  37. Hofmann PC, Weimann DS, Bitran JD et al. (1982) Surgical resection in patients with stage III MO, non small cell lung carcinoma of the lung. Proc Am Soc Clin Oncol 1: 147 A, C 571

    Google Scholar 

  38. Holmes EC, Gail M (1986) Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell, undifferentiated carcinoma. J Clin Oncol 4: 710–715

    PubMed  CAS  Google Scholar 

  39. Israel I, Breau JL, Morère JM (1986) Chimiothérapie préopératoire dans 57 cas de cancers bronchiques épidermoides. Analyse des responses des complications et de la survie. Neoadjuvant chemotherapy. Coll INSERM/John Libbey, Eurotext 137: 463–465

    Google Scholar 

  40. Johnson DH (1990) Chemotherapy for unresectable non-small cell lung cancer. Semin Oncol (Suppl 7 ) 17: 22–29

    Google Scholar 

  41. Johnson DH, Turrisi A, Pass HI (1996) Combined-modality treatment for locally advanced non-small cell lung cancer, chap 59. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT (eds) Lung cancer: Principles and practice. Lippincott-Raven, Philadelphia, pp 863–873

    Google Scholar 

  42. Joss PA, Brunner KW (1985) Die Chemotherapie der nichtkleinzelligen Bronchialkarzinome. In: Seeber S, Niederle S (Hrsg) Interdisziplinäre Therapie des Bronchialkarzinoms. Springer, Berlin Heidelberg New York Tokio, S 75–94

    Google Scholar 

  43. Kaasa S, Mastekaase A, Stokke I, Naess S (1988) Validation of a quality of life questionaire for use in clinical trials for treatment of patients with inoperable lung cancer. Eur J Cancer Clin Oncol 24: 691–791

    Article  PubMed  CAS  Google Scholar 

  44. Kaasa S, Lund E, Thorud E, Hatlevoll R, Host H (1991) Symptomatic treatment versus combination chemotherapy for patients with extensive non-small cell lung cancer. Cancer 67: 243–2447

    Article  Google Scholar 

  45. Kenis Y (1980) Surgical adjuvant chemotherapy in non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phvs 6: 1075–1977

    Article  CAS  Google Scholar 

  46. Klastersky J, Sculier JP (1985) Chemotherapy of non-small cell lung cancer. Semin Oncol 12: 38–48

    PubMed  CAS  Google Scholar 

  47. Klastersky J (1985) VP16 and cisplatin in the treatment of non-small cell lung cancer. Semin Oncol 12: 17–20

    PubMed  CAS  Google Scholar 

  48. Klastersky J (1994) New drug for therapy of non-small cell lung cancer. Lung Cancer (Suppl 3 ) 11: 139–149

    Google Scholar 

  49. Kris MG, Gralla RJ, Wertheim MS et al. (1986) Trial of the combination of mitomycin, vindesine and cisplatin in patients with advanced non-small cell lung cancer. Cancer Treat Rev 70: 1091–1096

    CAS  Google Scholar 

  50. Kris MG, Gralla RJ, Martini M, Stampleman LV, Burke MT (1987) Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer. Surg Clin N Am 67: 1051–1059

    PubMed  CAS  Google Scholar 

  51. Lad T, Rubenstein L, Sadeghi A (1988) The benefit of adjuvant treatment for resected locally advanced non small cell lung cancer. J Clin Oncol 6: 9–17

    Google Scholar 

  52. Legha SS, Muggia FM (1979) Adjuvant chemotherapy in lung cancer; an appraisal of past studies. In: Muggia FM, Rozencweig (eds) Lung cancer, progress in therapeutic research. Raven, New York, p 405–410

    Google Scholar 

  53. Le Chevalier T, Arriagada R, Quiox E et al. (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: first analysis of a randomized trial in 353 patients. Natl Cancer Inst 83: 417–423

    Article  Google Scholar 

  54. Loonbey WB, Goldie JH, Little JB et al. (1985) Alternating of chemotherapy and radiotherapy in cancer management. 1. Summary of the division of cancer treatment workshop. Cancer Treat Rep 69: 769–775

    Google Scholar 

  55. Manegold C, Pawel J von, Conte PF. for the Randomised Trial Group (1996) Randomised Phase 2 Study of gemcitabine (GEM) versus cisplatin/etoposide (C/E) in patients with advanced non-small cell lung cancer (NSCLC). Ann Oncol 7 (Suppl 5): 3 (Abstr 30)

    Google Scholar 

  56. Manegold C, Bergman B, Chemaissani A et al. (1997) Single agent gemcitabine versus cisplatinetoposiae: Early results of a randomised phase II study in locally advanced or metastatic non-small cell lung cancer. Ann Oncol (May/June)

    Google Scholar 

  57. Martini N, Kris MG, Gralla et al. (1988) The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2M0). Ann Thorac Surg 45: 370–379

    Article  PubMed  CAS  Google Scholar 

  58. Mattson K, Holsti LR, Holsti P et al. (1988) Inoperable non-small cell lung cancer: Radiation with or without chemotherapy. Eur J Cancer Clin Oncol 24: 477–482

    Article  PubMed  CAS  Google Scholar 

  59. Morton RF, Jett JR, McGinnis WL et al. (1991) Thoracic radiation therapy alone compared with combined chemo-radiotherapy for locally unresectable non-small cell lung cancer. Ann Intern Med 115: 681–686

    PubMed  CAS  Google Scholar 

  60. Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311: 899–909

    Article  Google Scholar 

  61. Pass HI, Pogrebniak HW, Steinberg SM, Mulshine J, Minna JD (1992) Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 53: 992–997

    Article  PubMed  CAS  Google Scholar 

  62. Pisters KMW, Kries MG, Gralla RJ, Martini N (1990) Preoperative chemotherapy in stage IIIA non-small cell cancer: an analysis of a trial in patients with clinically apparent mediastinal node involvement. In: Salmon SE (ed) Adjuvant chemotherapy of cancer IV. Saunders, Philadelphia, pp 133–137

    Google Scholar 

  63. Pujol JL, Rossi JF, LeChevalier T et al. (1990) Pilot study of neoadjuvant ifosfamide, cispla- tin, and etoposide in locally advanced non-small cell lung cancer. Eur J Cancer 26: 798–801

    Article  PubMed  CAS  Google Scholar 

  64. Rapp E, Pater JL, Willan A et al. (1988) Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer — report of a Canadian multicenter randomized trial. J Clin Oncol 6: 633–641

    PubMed  CAS  Google Scholar 

  65. Rebello J, Aramendia JM, Bilbao I et al. (1993) Neoadjuvant intra-arterial (IA) chemotherapy for stage III non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 12: 346, Al 161

    Google Scholar 

  66. Roseli R, Gomez-Condina J, Camps C et al. (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330: 153–158

    Article  Google Scholar 

  67. Roth JA, Fossella F, Komaki R et al. (1994) A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage III non-small cell lung cancer. Natl Cancer Inst 86: 673–680

    Article  CAS  Google Scholar 

  68. Sandler AB, Buzaid AC (1992) Lung cancer: A review of current therapeutic modalities. Lung 170: 249–265

    Article  PubMed  CAS  Google Scholar 

  69. Sause W, Scott C, Taylor S et al. (1994) RTOG 8808 ECOG 4588. Preliminary analysis of a phase II trial in regionally advanced unresectable non-small cell lung cancer. Proc Am Assoc Clin Oncol 13: 325 (Abstract)

    Google Scholar 

  70. Schaake-Koning C, Bogaert W van den, Dalesio O et al. (1992) Effects of concomitant cis- platin and radiotherapy in inoperable non-small cell lung cancer. New Engl J Med 326: 524–530

    Article  PubMed  CAS  Google Scholar 

  71. Seeber S, Eberhardt W, Wilke H, Stamatis G (1996) Multimodale präoperative Induktionstherapie unter Einschluß von Chemotherapie und Chemoradiotherapie: Ein neuer kurativer Therapieansatz beim lokal weit fortgeschrittenen nichtkleinzelligen Bronchialkarzinom. Abstract-Bd 22, Deutscher Krebskongreß 02. 02. 94

    Google Scholar 

  72. Sorensen JB (1993) Treatment of non-small cell lung cancer: New cytostatic agents. Lung Cancer 10: 173–187

    Article  PubMed  CAS  Google Scholar 

  73. Souquet PJ, Chauvin F, Boissel JP et al. (1993) Polychemotherapy in advanced non-small cell lung cancer: a meta-analysis. Lancet 342: 19–21

    Article  PubMed  CAS  Google Scholar 

  74. Spain R (1988) Neoadjuvant mitomycin C, cisplatin, and infusion vinblastine in locally and regionally advanced non-small cell lung cancer: Problems and progress from the perspective or long-term follow-up. Semin Oncol 15 (Suppl 4): 6–15

    PubMed  CAS  Google Scholar 

  75. Strauss GM, Langer MP, Elias AD, Skarin AT, Sugerbaker DJ (1992) Multimodality treatment of stage IIIA non-small cell lung carcinoma: A critical review of the literature and strategies for future research. J Clin Oncol 10: 829–838

    PubMed  CAS  Google Scholar 

  76. Takita H, Regal AM, Antkowiak JG et al. (1986) Chemotherapy followed by lung resection in inoperable non-small cell lung carcinoma due to locally far-advanced disease. Cancer 57: 630–635

    Article  PubMed  CAS  Google Scholar 

  77. Takita H, Antkowiak J, Vaickus L et al. (1993) Chemotherapy (PACC) and surgery in stage III NSCLC. Proc Am Soc Clin Oncol 12: 349 A, 1172

    Google Scholar 

  78. Thatcher N, Ranson M, Lee SM, Niven R, Anderson H (1995) Chemotherapy in non-small cell lung cancer. Symposium article. Ann Oncol 6 (Suppl 1): 83–95

    PubMed  Google Scholar 

  79. Tubiana M, Arriagada R, Cosset JM (1985) Sequencing of arugs and radiation. Cancer 55: 2131–2139

    Article  PubMed  CAS  Google Scholar 

  80. Van Houtte P (1995) Induction of concomitant chemotherapy and radiotherapy for non- small cell lung cancer. Myth or reality. Symposium article. Ann Oncol 6 (Suppl 3): 37–40

    Google Scholar 

  81. Woods RL, Williams CJ, Levi J et al. (1990) A randomized trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. Br J Cancer 61: 608–611

    Article  PubMed  CAS  Google Scholar 

  82. Zandwijk N van, Giaccone G (1996) Treatment of metastatic non-small cell lung cancer. Curr Opin Oncol 8: 120–125

    Article  PubMed  Google Scholar 

Download references

Authors
  1. C. Manegold
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Drings
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Innere Medizin/Onkologie, Thoraxklinik Heidelberg-Rohrbach der Landesversicherungsanstalt Baden, Amalienstr. 5, 69126, Heidelberg, Germany

    P. Drings

  2. Ziegelhäuser Landstraße 65, 69117, Heidelberg, Germany

    I. Vogt-Moykopf

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Manegold, C., Drings, P. (1998). Chemotherapie des nichtkleinzelligen Lungenkarzinoms. In: Drings, P., Vogt-Moykopf, I. (eds) Thoraxtumoren. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72041-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72041-3_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-72042-0

  • Online ISBN: 978-3-642-72041-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation